These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9242538)
1. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels. Wang JM; Zheng H; Blaivas M; Kurachi K Blood; 1997 Aug; 90(3):1075-82. PubMed ID: 9242538 [TBL] [Abstract][Full Text] [Related]
2. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845 [TBL] [Abstract][Full Text] [Related]
3. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Yao SN; Smith KJ; Kurachi K Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074 [TBL] [Abstract][Full Text] [Related]
4. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells]. Hou J; Wang J; Min B Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368 [TBL] [Abstract][Full Text] [Related]
6. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Miao CH; Thompson AR; Loeb K; Ye X Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of recombinant adeno-associated virus-mediated gene transfer. Malik AK; Monahan PE; Allen DL; Chen BG; Samulski RJ; Kurachi K J Virol; 2000 Apr; 74(8):3555-65. PubMed ID: 10729130 [TBL] [Abstract][Full Text] [Related]
8. Regulation of human factor IX expression using doxycycline-inducible gene expression system. Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607 [TBL] [Abstract][Full Text] [Related]
9. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187 [TBL] [Abstract][Full Text] [Related]
10. Increment of hFIX expression with endogenous intron 1 in vitro. Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559 [TBL] [Abstract][Full Text] [Related]
11. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero. Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387 [TBL] [Abstract][Full Text] [Related]
12. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells. Chen H; Yao H; Huang L; Shen Q; Jia W; Xue J Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501 [TBL] [Abstract][Full Text] [Related]
13. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero. Chen XG; Zhu HZ; Gong JL; Li F; Xue JL Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633 [TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice. Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017 [TBL] [Abstract][Full Text] [Related]
15. Construction of mammary gland-specific expression vectors for human clotting factor IX and its secretory expression in goat milk. Zhang K; Lu D; Xue J; Huang Y; Huang S Chin J Biotechnol; 1997; 13(4):271-6. PubMed ID: 9631263 [TBL] [Abstract][Full Text] [Related]
16. Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs. Zhang J; Xu L; Haskins ME; Parker Ponder K Blood; 2004 Jan; 103(1):143-51. PubMed ID: 12969967 [TBL] [Abstract][Full Text] [Related]
17. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366 [TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle-specific expression of human blood coagulation factor IX rescues factor IX deficiency mouse by AAV-mediated gene transfer. Lai L; Chen L; Wang J; Zhou H; Lu D; Wang Q; Gao X; Qiu X; Xue J Sci China C Life Sci; 1999 Dec; 42(6):628-34. PubMed ID: 18726486 [TBL] [Abstract][Full Text] [Related]
19. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B]. Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526 [TBL] [Abstract][Full Text] [Related]
20. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Nathwani AC; Davidoff AM; Hanawa H; Hu Y; Hoffer FA; Nikanorov A; Slaughter C; Ng CY; Zhou J; Lozier JN; Mandrell TD; Vanin EF; Nienhuis AW Blood; 2002 Sep; 100(5):1662-9. PubMed ID: 12176886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]